Constitutional de novo deletion of the FBXW7 gene in a patient with focal segmental glomerulosclerosis and multiple primitive tumors

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Roversi, Gaia ^a,e   Picinelli, Chiara ^b   Bestetti, Ilaria ^b,c   Crippa, Milena ^b   Perotti, Daniela ^d   Ciceri, Sara ^d   Saccheri, Fabiana ^e   Collini, Paola ^d   Poliani, Pietro L ^f   Catania, Serena ^d   Peissel, Bernard ^d   Pagni, Fabio ^a   Russo, Silvia ^b   Peterlongo, Paolo ^g   Manoukian, Siranoush ^d   Finelli, Palma ^b,c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; TFE3 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMAN; KARYOTYPE; MALE; METABOLISM; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY;

ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MUTATIONAL ANALYSIS; F-BOX PROTEINS; FEMALE; GENE DELETION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPE; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; UBIQUITIN-PROTEIN LIGASES;

EID: 84945237290     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15454     Document Type: Article

References (26)

1. Welcker, M., Clurman, B. E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer. 8, 83-93 (2008).
2. Wang, Z. et al. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett. 586, 1409-1418 (2012).
3. Inuzuka, H. et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature. 471, 104-109 (2011).
4. Berger, A. H., Knudson, A. G., Pandolfi, P. P. A continuum model for tumour suppression. Nature. 476, 163-169 (2011).
5. Davis, H., Tomlinson, I. CDC4/FBXW7 and the 'just enough' model of tumourigenesis. J Pathol. 227, 131-135 (2012).
6. Wang, Z. et al. The two faces of FBW7 in cancer drug resistance. Bioessays. 33, 851-859 (2011).
7. Mao, J. H. et al. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science. 321, 1499-1502 (2008).
8. Williams, R. D. et al. Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor. Clin Cancer Res. 16, 2036-2045 (2010).
9. Kuiper, R. P. et al. The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer. Cancer Genet Cytogenet. 195, 105-111 (2009).
10. Scott, R. H. et al. Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet. 40, 1329-1334 (2008).
11. Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002). Available at: http://genome.ucsc. edu/(date of access: 20/05/2015).
12. Firth, H. V. et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Am J Hum Genet. 84, 524-533 (2009) Available at: https://decipher.sanger.ac.uk/(date of access: 20/05/2015).
13. Argani, P. et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 27, 750-761 (2003).
14. Kuiper, R. P., Ligtenberg, M. J. L., Hoogerbrugge, N., van Kessel, A. G. Germline copy number variation and cancer risk. Curr Opin Genet Dev. 20, 282-289 (2010).
15. Dome, J. S., Huff, V. Wilms Tumor Overview. 2003 Dec 19 [Updated 2013 Sep 19]. In: Pagon, R.A. et al. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1294/(date of access: 29/01/2015).
16. Huff, V. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer. 11, 111-121 (2011).
17. Vuononvirta, R. et al. Perilobar Nephrogenic Rests Are Nonobligate Molecular Genetic Precursor Lesions of Insulin-Like Growth Factor-II-Associated Wilms Tumors. Clin Cancer Res. 14, 7635-7644 (2008).
18. Niranjan, T. et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med. 14, 290-298 (2008).
19. Mallouk, A., Pham, P. T., Pham, P. C. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol. 10, 284-289 (2006).
20. Song, J. H., Schnittke, N., Zaat, A., Walsh, C. S., Miller, C. W. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias. Leuk Res. 32, 1751-1755 (2008).
21. Perez-Losada, J., Wu, D., DelRosario, R., Balmain, A., Mao, J. H. Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 as Germline Modifier of Tumor Susceptibility. PloS One. doi: 10.1371/journal.pone.0031301 (2012).
22. Yu, J. C. et al. Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis. 30, 1562-1570 (2009).
23. Rajagopalan, H. et al. Inactivation of hCDC4 can cause chromosomal instability. Nature. 428, 77-81 (2004).
24. Oeffinger, K. C., Bhatia, S. Second primary cancers in survivors of childhood cancer. Lancet. 374, 1484-1485 (2009).
25. Macher-Goeppinger, S. et al. Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol. 25, 308-315 (2012).
26. Van Beers, E. H. et al. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 94, 333-337 (2006).